252 related articles for article (PubMed ID: 30457023)
1. Psoriasis and cardiovascular disease: the elusive link.
Manolis AA; Manolis TA; Melita H; Manolis AS
Int Rev Immunol; 2019; 38(1):33-54. PubMed ID: 30457023
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular morbidity in psoriasis: epidemiology, pathomechanisms, and clinical consequences.
Boehncke WH; Boehncke S
G Ital Dermatol Venereol; 2008 Oct; 143(5):307-13. PubMed ID: 18833072
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Risk in Psoriasis: Current State of the Art.
Dattilo G; Borgia F; Guarneri C; Casale M; Bitto R; Morabito C; Signorelli S; Katsiki N; Cannavò SP
Curr Vasc Pharmacol; 2019; 17(1):85-91. PubMed ID: 29149819
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.
Horreau C; Pouplard C; Brenaut E; Barnetche T; Misery L; Cribier B; Jullien D; Aractingi S; Aubin F; Joly P; Le Maître M; Ortonne JP; Paul C; Richard MA
J Eur Acad Dermatol Venereol; 2013 Aug; 27 Suppl 3():12-29. PubMed ID: 23845149
[TBL] [Abstract][Full Text] [Related]
5. Novel anti-inflammatory therapies to reduce cardiovascular burden of psoriasis.
Piros ÉA; Szilveszter B; Vattay B; Maurovich-Horvat P; Szalai K; Dósa E; Merkely B; Holló P
Dermatol Ther; 2021 Jan; 34(1):e14721. PubMed ID: 33373079
[TBL] [Abstract][Full Text] [Related]
6. Polyarticular evolution and late-onset psoriasis may be associated with cardiovascular disease in psoriatic arthritis.
Queiro R; Lorenzo A; Tejón P; Pardo E; Coto P; Ballina J
Int J Rheum Dis; 2019 Feb; 22(2):269-274. PubMed ID: 30398011
[TBL] [Abstract][Full Text] [Related]
7. [Comorbidities in psoriasis].
Weisenseel P; Prinz JC
Dtsch Med Wochenschr; 2010 Jul; 135(28-29):1446-50. PubMed ID: 20614408
[No Abstract] [Full Text] [Related]
8. [Is psoriasis a dependent cardiovascular risk factor?].
Wakkee M; de Jong EM
Ned Tijdschr Geneeskd; 2013; 157(11):A5417. PubMed ID: 23484510
[TBL] [Abstract][Full Text] [Related]
9. Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis.
Samarasekera EJ; Neilson JM; Warren RB; Parnham J; Smith CH
J Invest Dermatol; 2013 Oct; 133(10):2340-2346. PubMed ID: 23528816
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular disease in psoriatic post-menopausal women.
Pietrzak A; Czuczwar P; Mosiewicz J; Paszkowski T; Chodorowska G; Bartosinska J; Gerkowicz A; Paluszkiewicz P; Freud T; Cohen AD
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1231-4. PubMed ID: 25073722
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis and its comorbidities.
Onumah N; Kircik LH
J Drugs Dermatol; 2012 May; 11(5 Suppl):s5-10. PubMed ID: 22644770
[TBL] [Abstract][Full Text] [Related]
12. Investigating the Link between Psoriasis and Cardiovascular Disease: Current Evidence, Therapeutic Implications and Perspectives.
Kapniari E; Papadimitriou P; Dalamaga M; Makavos G; Piaserico S; Egeberg A; Ikonomidis I; Papadavid E
Curr Vasc Pharmacol; 2020; 18(6):592-609. PubMed ID: 32445456
[TBL] [Abstract][Full Text] [Related]
13. Cardiometabolic Disorders in Psoriatic Disease.
Sobchak C; Eder L
Curr Rheumatol Rep; 2017 Aug; 19(10):63. PubMed ID: 28844116
[TBL] [Abstract][Full Text] [Related]
14. Psoriasis and cardiovascular disorders.
Ryan C; Menter A
G Ital Dermatol Venereol; 2012 Apr; 147(2):179-87. PubMed ID: 22481581
[TBL] [Abstract][Full Text] [Related]
15. [Comorbidities and psoriasis. Impact on clinical practice].
Gerdes S; Mrowietz U
Hautarzt; 2012 Mar; 63(3):202-13. PubMed ID: 22373901
[TBL] [Abstract][Full Text] [Related]
16. From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies.
Hugh J; Van Voorhees AS; Nijhawan RI; Bagel J; Lebwohl M; Blauvelt A; Hsu S; Weinberg JM
J Am Acad Dermatol; 2014 Jan; 70(1):168-77. PubMed ID: 24184141
[TBL] [Abstract][Full Text] [Related]
17. Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review.
Armstrong AW; Brezinski EA; Follansbee MR; Armstrong EJ
Curr Pharm Des; 2014; 20(4):500-12. PubMed ID: 23565631
[TBL] [Abstract][Full Text] [Related]
18. Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms.
Yim KM; Armstrong AW
Rheumatol Int; 2017 Jan; 37(1):97-105. PubMed ID: 27221457
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review.
Mehta H; Narang T; Dogra S; Handa S; Hatwal J; Batta A
Vasc Health Risk Manag; 2024; 20():215-229. PubMed ID: 38745849
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives.
Boehncke WH; Boehncke S
Curr Rheumatol Rep; 2012 Aug; 14(4):343-8. PubMed ID: 22562431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
